California Stem Cell, Inc. and Families of Spinal Muscular Atrophy Announce Completion of Pre-IND Meeting with FDA for …
IRVINE, Calif.—-California Stem Cell, Inc. and Families of Spinal Muscular Atrophy announced today that they have completed a formal pre-Investigational New Drug meeting with the Food and Drug Administration for guidance on the clinical and regulatory pathway and requirements for submission of an IND to initiate human trials for a stem cell-derived motor neuron replacement therapy for Spinal …
[Read the full article here]Related News:
Families of Spinal Muscular Atrophy and California Stem Cell, Inc. Motor Graft Project 2010 Update
Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug Designation
Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan …